200 results on '"Nakashima, Kazuko"'
Search Results
2. Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
3. Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
4. Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
5. Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer
6. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model
7. Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer
8. Preclinical Evaluation of Biodistribution and Toxicity of [ 211 At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.
9. Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine
10. Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
11. Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with 211At Using Implanted Mouse Tumor
12. Effect to Therapy of Sodium-Iodine Symporter Expression by Alpha-Ray Therapeutic Agent via Sodium/Iodine Symporter
13. Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
14. Dioxetane Derivative Containing Carboxy Group as a Chemiluminophore‐Introducing Reagent
15. Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
16. Substrate Study for Dihydroxyboryl Astatine Substitution Reaction with Fibroblast Activation Protein Inhibitor (FAPI)
17. Comparison of the Therapeutic Effects of [211At]NaAt and [131I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model
18. Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression
19. Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.
20. Relationship between Restless legs syndrome associated symptoms and presence of depression during pregnancy
21. Role of Mel1/Prdm16 in bone differentiation and morphology
22. Mathematical Model for Evaluation of Tumor Response in Targeted Radionuclide Therapy with 211 At Using Implanted Mouse Tumor.
23. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35
24. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model
25. Comparison of the Therapeutic Effects of [ 211 At]NaAt and [ 131 I]NaI in an NIS-Expressing Thyroid Cancer Mouse Model.
26. Comparison of the Therapeutic Effects of [211At]NaAt and [131I]NaI in an NIS-expressing Thyroid Cancer Mouse Model
27. Idiopathic and secondary restless legs syndrome during pregnancy in Japan: Prevalence, clinical features and delivery-related outcomes
28. Efficient gene delivery in human and rodent mast cells using adenovirus vectors
29. An association study of asthma and related phenotypes with polymorphisms in negative regulator molecules of the TLR signaling pathway
30. Differentiation, distribution, and chemical state of intracellular trace elements in LAD2 mast cell line
31. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma
32. α‐Emitting cancer therapy using 211 At‐AAMT targeting LAT1
33. Dispersion of Alpha-Nuclides during Animal Experiments
34. Association between genetic variation in the gene for death-associated protein-3 (DAP3) and adult asthma
35. Association between IFNA genotype and the risk of sarcoidosis
36. Enterprise failures correlate positively with suicide rate for both sexes in Japan
37. Diagnosis and prevention of diseases induced by isocyanate
38. Review of the occupational exposure to isocyanates: Mechanisms of action
39. Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model.
40. Association of the RIP2 Gene with Childhood Atopic Asthma
41. Development of high‐resolution YAP(Ce) x‐ray camera for the imaging of astatine‐211(At‐211) in small animals
42. Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice
43. Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [211At] NaAt in Mice: A Revisit
44. Increased Uptake of At-211 in Thyroid Gland by the Preparation with Ascorbic Acid for Targeted Alpha Therapy of Thyroid Cancer
45. 28. ADENOVIRUS VECTORS STIMULATE INNATE IMMUNITY VIA MYD88/TLR9-DEPENDENT AND-INDEPENDENT PATHWAYS
46. Functional Polymorphism in the Suppressor of Cytokine Signaling 1 Gene Associated with Adult Asthma
47. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes
48. Functional haplotypes of IL-12B are associated with childhood atopic asthma
49. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis
50. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.